USPTO serial 86837057
RED CAP PHARMACY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RED CAP PHARMACY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Farmington Hills, MI
Farmington Hills, MI
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, inhalants, sachets and pharmaceutical preparations and substances for the prevention and treatment of diseases, conditions, and disorders, all for the prevention and treatment of respiratory, cardiovascular, and eye diseases, conditions, and disorders; Pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculo-skeletal, osteoporosis, cardiovascular, cardiopulmonary, heart rhythm, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ocular, respiratory, inflammatory, hematology, neurological, gastrointestinal, kidney, hormonal, dermatological, psychiatric, autoimmune, immune, and nervous system related diseases, conditions, and disorders; Pharmaceutical preparations and substances for use in chemotherapy and for the treatment of cancer; Pharmaceutical preparations and substances, namely, antidepressants; Pharmaceutical preparations and substances for the treatment of diseases, conditions, and disorders, namely, for the treatment of diabetes; Pharmaceutical preparations and substances for diseases, conditions, and disorders, all for ocular or intraocular surgery; Pharmaceutical preparations and substances for the prevention and treatment of diseases, conditions, and disorders, namely, for use in dermatology and skin care and for treating skin conditions and disorders; Pharmaceutical preparations and substances for the treatment and relief of back pain, muscle pain, arthritis, and joint pain; Pharmaceutical preparations, namely, cough and cold preparations, sinus preparations, and sleep aids; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for use in urology; Pharmaceutical preparations and substances for the prevention and treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, and antifungal preparations and vaccines; and Pharmaceutical preparations and substances for the prevention and treatment of infectious diseases, blood disorders, coagulation, pain, inflammation, sepsis, alopecia, obesity, and cognitive disorders, conditions, and diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 5, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 5, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 11, 2017 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Dec 11, 2017 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Jun 24, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 22, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 22, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 22, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 6, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 4, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 4, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 4, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 4, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 5, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 10, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 10, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 20, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 28, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 28, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 21, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2016 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 2, 2016 | ALIE | ASSIGNED TO LIE | — |
| Feb 23, 2016 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 7, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2015 | NWAP | NEW APPLICATION ENTERED | — |